Blackstone Inc Context Therapeutics Inc. Transaction History
Blackstone Inc
- $22 Billion
- Q1 2025
A detailed history of Blackstone Inc transactions in Context Therapeutics Inc. stock. As of the latest transaction made, Blackstone Inc holds 2,440,330 shares of CNTX stock, worth $1.56 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,440,330
Previous 2,440,330
-0.0%
Holding current value
$1.56 Million
Previous $2.42 Million
38.39%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding CNTX
# of Institutions
47Shares Held
79MCall Options Held
0Put Options Held
0-
Bio Impact Capital LLC Cambridge, MA14.7MShares$9.41 Million1.66% of portfolio
-
Avidity Partners Management LP Dallas, TX7.48MShares$4.79 Million1.03% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.42MShares$4.75 Million0.16% of portfolio
-
Nextech Invest, Ltd. Zurich, V87.42MShares$4.75 Million1.06% of portfolio
-
Nextech Invest Ag7.42MShares$4.75 Million1.37% of portfolio
About Context Therapeutics Inc.
- Ticker CNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,966,100
- Market Cap $10.2M
- Description
- Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therape...